[Federal Register Volume 83, Number 227 (Monday, November 26, 2018)]
[Notices]
[Pages 60427-60428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25589]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)-RFA-IP-19-001, Surveillance for 
Respiratory Syncytial Virus (RSV) and Other Viral Respiratory 
Infections Among Native Americans/Alaskan Natives; RFA-IP-19-002, 
Increasing Influenza and Tdap Vaccination of Pregnant Women in 
Obstetric/Gynecologic Practices in Large Health Systems through Quality 
Improvement Interventions; and RFA-IP-19-003, Understanding and 
Improving Immunization Services Among Adult Hospital Inpatient and 
Observation/Clinical Decision Unit Settings.
    Date: March 19-20, 2019.
    Time: 10:00 a.m.-5:00 p.m., (EST).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road, NE, Mailstop E60, 
Atlanta, Georgia 30329, (404) 718-8833, [email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has

[[Page 60428]]

been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-25589 Filed 11-23-18; 8:45 am]
 BILLING CODE 4163-18-P